Article Details

Gait deficit device treatment for MS patients receives FDA authorisation

Retrieved on: 2021-06-17 07:52:30

Tags for this article:

Click the tags to see associated articles and topics

Gait deficit device treatment for MS patients receives FDA authorisation. View article details on hiswai:

Excerpt

Cambridge Consultants, part of Capgemini, and Helius Medical Technologies, have confirmed that a device they developed for short-term treatment of ...

Article found on: www.med-technews.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up